(Q36806639)

16 August 2017

1 reference

title

Disease staging and milestones (English)

1 reference

16 August 2017

Kiran Rabheru

1

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Canadian Journal of Neurological Sciences

16 August 2017

published in

1 reference

16 August 2017

volume

34 Suppl 1

1 reference

16 August 2017

page(s)

S62-6

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Defining meaningful change in Alzheimer's disease trials: the donepezil experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Severe impairment battery. A neuropsychological test for severely demented patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

The economic impact of the tacrine in the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Longitudinal study of quality of life in people with advanced Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Patient and caregiver characteristics associated with depression in caregivers of patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Hallucinations, delusions, and cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Evolution of depressive symptoms in Alzheimer disease: one-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Depression in Alzheimer's disease: overview and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Survival in Alzheimer's disease and vascular dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Natural history of cognitive decline in the old old

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Longitudinal course of normal aging and progressive dementia of the Alzheimer's type: a prospective study of 106 subjects over a 3.6 year mean interval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Alzheimer's disease is a vasocognopathy: a new term to describe its nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

Canadian Outcomes Study in Dementia: study methods and patient characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

7 January 2021

Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

7 January 2021

Subjective burden of husbands and wives as caregivers: a longitudinal study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

7 January 2021

Natural history of aggressive behaviour in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

7 January 2021

Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

7 January 2021

Longitudinal Study of Quality of Life in People with Advanced Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

7 January 2021

Intracranial volume in mild cognitive impairment, Alzheimer's disease and vascular dementia: evidence for brain reserve?

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000559X

7 January 2021

10.1017/S031716710000559X

Identifiers

DOI

1 reference

16 August 2017

1 reference